{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:07:59Z","timestamp":1792217279889,"version":"4.4.0"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Evidence-based clinical practice guidelines regarding high-flow nasal cannula (HFNC) use for respiratory support in critically ill children are lacking. Therefore, we aimed to determine the risk factors for early HFNC failure to reduce the failure rate and prevent adverse consequences of HFNC failure in children with acute respiratory dysfunction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Demographic and laboratory data were compared among patients, admitted to the pediatric intensive care unit between January 2017 and December 2018, who were included in a retrospective cohort study. Univariate and multivariate analyses were performed to determine risk factors for eventual entry into the predictive model for early HFNC failure and to perform an external validation study in a prospective observational cohort study from January to February 2019. Further, the association of clinical indices and trends pre- and post-treatment with HFNC treatment success or failure in these patients was dynamically observed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 348 pediatric patients were included, of these 282 (81.0%) were included in the retrospective cohort study; HFNC success was observed in 182 patients (64.5%), HFNC 0\u201324 h failure in 74 patients (26.2%), and HFNC 24\u201348 h failure in 26 patients (9.2%). HFNC 24 h failure was significantly associated with the pediatric risk of mortality (PRISM) III score [odds ratio, 1.391; 95% confidence interval (CI): 1.249\u20131.550], arterial partial pressure of carbon dioxide-to-arterial partial pressure of oxygen (PaCO<jats:sub>2<\/jats:sub>\/PaO<jats:sub>2<\/jats:sub>) ratio (odds ratio, 38.397; 95% CI: 6.410\u2013230.013), and respiratory rate-oxygenation (ROX) index (odds ratio, 0.751; 95% CI: 0.616\u20130.915). The discriminating cutoff point for the new scoring system based on the three risk factors for HFNC 24 h failure was \u2265 2.0 points, with an area under the receiver operating characteristic curve of 0.794 (95% CI, 0.729\u20130.859, <jats:italic>P<\/jats:italic> &amp;lt; 0.001), sensitivity of 68%, and specificity of 79%; similar values were noted on applying the model to the prospective observational cohort comprising 66 patients (AUC = 0.717, 95% CI, 0.675\u20130.758, sensitivity 83%, specificity 44%, <jats:italic>P<\/jats:italic> = 0.009). In this prospective cohort, 11 patients with HFNC failure had an upward trend in PaCO<jats:sub>2<\/jats:sub>\/PaO<jats:sub>2<\/jats:sub> ratio and downward trends in respiratory failure index (P\/F ratio) and ROX index; however, opposite directions of change were observed in 55 patients with HFNC success. Furthermore, the fractional changes (FCs) in PaCO<jats:sub>2<\/jats:sub>\/PaO<jats:sub>2<\/jats:sub> ratio, P\/F ratio, percutaneous oxygen saturation-to-fraction of inspired oxygen (S\/F) ratio, and ROX index at 2 h post-HFNC therapy onset were statistically significant between the two groups (all, <jats:italic>P<\/jats:italic> &amp;lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In the pediatric patients with acute respiratory insufficiency, pre-treatment PRISM III score, PaCO<jats:sub>2<\/jats:sub>\/PaO<jats:sub>2<\/jats:sub> ratio, and ROX index were risk factors for HFNC 24 h failure, and the direction and magnitude of changes in the PaCO<jats:sub>2<\/jats:sub>\/PaO<jats:sub>2<\/jats:sub> ratio, P\/F ratio, and ROX index before and 2 h after HFNC treatment were warning indicators for HFNC 24 h failure. Further close monitoring should be considered for patients with these conditions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.979944","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T07:19:55Z","timestamp":1661239195000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of risk factors for the failure of respiratory support with high-flow nasal cannula oxygen therapy in children with acute respiratory dysfunction: A case\u2013control study"],"prefix":"10.3389","volume":"10","author":[{"given":"Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/PCC.0b013e3181ce7427","article-title":"Three decades of pediatric intensive care: Who was admitted, what happened in intensive care, and what happened afterward.","volume":"11","author":"Namachivayam","year":"2010","journal-title":"Pediatr Crit Care Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"170028","DOI":"10.1183\/16000617.0028-2017","article-title":"Nasal high flow therapy: A novel treatment rather than a more expensive oxygen device.","volume":"26","author":"Ischaki","year":"2017","journal-title":"Eur Respir Rev."},{"key":"B3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.4187\/respcare.04577","article-title":"High-flow nasal cannula oxygen therapy in adults: Physiological benefits, indication, clinical benefits, and adverse effects.","volume":"61","author":"Nishimura","year":"2016","journal-title":"Respir Care."},{"key":"B4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3345\/kjp.2019.00626","article-title":"High-flow nasal cannula oxygen therapy in children: A clinical review.","volume":"63","author":"Kwon","year":"2020","journal-title":"Clin Exp Pediatr."},{"key":"B5","doi-asserted-by":"publisher","first-page":"885066620968041","DOI":"10.1177\/0885066620968041","article-title":"Failure of high flow nasal cannula and subsequent intubation is associated with increased mortality as compared to failure of non-invasive ventilation and mechanical ventilation alone: A real-world retrospective analysis.","volume":"37","author":"Miller","year":"2020","journal-title":"J Intensive Care Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1093\/pch\/pxaa087","article-title":"Factors associated with treatment failure of high-flow nasal cannula among children with bronchiolitis: A single-centre retrospective study.","volume":"26","author":"D\u2019Alessandro","year":"2021","journal-title":"Paediatr Child Health."},{"key":"B7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.hrtlng.2020.03.018","article-title":"High flow nasal cannula is a good treatment option for COVID-19.","volume":"49","author":"Geng","year":"2020","journal-title":"Heart lung."},{"key":"B8","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12890-020-01354-w","article-title":"Application of high-flow nasal cannula in hypoxemic patients with COVID-19: A retrospective cohort study.","volume":"20","author":"Hu","year":"2020","journal-title":"BMC Pulm Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13054-018-1990-4","article-title":"Systematic review of the high-flow nasal cannula for adult patients.","volume":"22","author":"Helviz","year":"2018","journal-title":"Crit care."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s00134-015-3804-3","article-title":"Failure of high-flow nasal cannula and delayed intubation: A new harmful sequence?","volume":"41","author":"Esquinas","year":"2015","journal-title":"Intensive Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00134-015-3693-5","article-title":"Failure of high-flow nasal cannula therapy may delay intubation and increase mortality.","volume":"41","author":"Kang","year":"2015","journal-title":"Intensive Care Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"50.e","DOI":"10.1016\/j.jpeds.2016.02.051","article-title":"High flow nasal cannula use is associated with increased morbidity and length of hospitalization in extremely low birth weight infants.","volume":"173","author":"Taha","year":"2016","journal-title":"J Pediatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/ppul.24318","article-title":"Comparison of heated humidified high-flow nasal cannula flow rates (1-L\u25aa kg\u25aa min-1 vs 2-L\u25aa kg\u25aa min-1) in the management of acute bronchiolitis.","volume":"54","author":"Yurtseven","year":"2019","journal-title":"Pediatr Pulmonol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.7499\/j.issn.1008-8830.2019.07.007","article-title":"High-risk factors for early failure of high-flow nasal cannula oxygen therapy in children.","volume":"21","author":"Liu","year":"2019","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi."},{"key":"B15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s15006-015-2757-3","article-title":"Medications for respiratory insufficiency and exacerbations.","volume":"157","author":"Bischoff","year":"2015","journal-title":"MMW Fortschr Med."},{"key":"B16","first-page":"264","author":"Changchong","year":"2014","journal-title":"Respiratory diseases."},{"key":"B17","first-page":"1174","author":"Shen-Kunling","year":"2011","journal-title":"Pneumonia."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.13201\/j.issn.1009-5918.2019.01.001","article-title":"Expert consensus on noninvasive positive pressure ventilation emergency clinical practice (2018).","volume":"20","author":"Xin-Chao","year":"2019","journal-title":"J Clin Emergency Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.prrv.2013.12.002","article-title":"The evidence for high flow nasal cannula devices in infants.","volume":"15","author":"Haq","year":"2014","journal-title":"Paediatr Respir Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jpeds.2017.06.077","article-title":"High flow nasal cannula flow rates: New data worth the weight.","volume":"189","author":"Shein","year":"2017","journal-title":"J Pediatr."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1007\/s00134-018-5343-1","article-title":"A multicenter randomized controlled trial of a 3-L\/kg\/min versus 2-L\/kg\/min high-flow nasal cannula flow rate in young infants with severe viral bronchiolitis (TRAMONTANE 2).","volume":"44","author":"Mil\u00e9si","year":"2018","journal-title":"Intensive Care Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ppul.10425","article-title":"Use of a respiratory clinical score among different providers.","volume":"37","author":"Liu","year":"2004","journal-title":"Pediatr Pulm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40560-020-00458-z","article-title":"Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate.","volume":"8","author":"Goh","year":"2020","journal-title":"J Intensive Care."},{"key":"B24","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4187\/respcare.03423","article-title":"Use of high-flow nasal Cannula oxygen therapy in subjects with ARDS: A 1-year observational study.","volume":"60","author":"Messika","year":"2015","journal-title":"Respir Care."},{"key":"B25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jcrc.2012.04.006","article-title":"High-flow nasal therapy in adults with severe acute respiratory infection: A cohort study in patients with 2009 influenza A\/H1N1v.","volume":"27","author":"Rello","year":"2012","journal-title":"J Crit Care."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1136\/hrt.2003.025338","article-title":"Predictors of failure in infants with viral bronchiolitis treated with high-flow, high-humidity nasal cannula therapy.","volume":"13","author":"Abboud","year":"2012","journal-title":"Pediatr Crit Care Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1017\/S1049023X15000199","article-title":"Factors associated with failure of non-invasive positive pressure ventilation in a critical care helicopter emergency medical service.","volume":"30","author":"Lee","year":"2015","journal-title":"Prehosp Disaster Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fped.2020.00403","article-title":"Glycemic variability: An independent predictor of mortality and the impact of age in pediatric intensive care unit.","volume":"8","author":"Du","year":"2020","journal-title":"Front Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jcrc.2017.09.176","article-title":"High-flow oxygen therapy in immunocompromised patients with acute respiratory failure: A review and meta-analysis.","volume":"43","author":"Huang","year":"2018","journal-title":"J Crit Care."},{"key":"B30","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1177\/0885066617705118","article-title":"Effect of high-flow nasal cannula oxygen therapy versus conventional oxygen therapy and noninvasive ventilation on reintubation rate in adult patients after extubation: A systematic review and meta-analysis of randomized controlled trials.","volume":"33","author":"Huang","year":"2018","journal-title":"J Intensive Care Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":".e1","DOI":"10.1016\/j.ajem.2016.02.020","article-title":"High-flow nasal cannula oxygen supply as treatment in hypercapnic respiratory failure.","volume":"34","author":"Lepere","year":"2016","journal-title":"Am J Emerg Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1177\/1753465814521890","article-title":"The use of high-flow nasal oxygen therapy in the management of hypercarbic respiratory failure.","volume":"8","author":"Millar","year":"2014","journal-title":"Ther Adv Respir Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.ajem.2015.07.060","article-title":"Changes in arterial blood gases after use of high-flow nasal cannula therapy in the ED.","volume":"33","author":"Jeong","year":"2015","journal-title":"Am J Emerg Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":".e9","DOI":"10.1016\/j.jcrc.2011.07.075","article-title":"Impact of high-flow nasal cannula oxygen therapy on intensive care unit patients with acute respiratory failure: A prospective observational study.","volume":"27","author":"Sztrymf","year":"2012","journal-title":"J Crit Care."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","article-title":"An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy.","volume":"199","author":"Roca","year":"2019","journal-title":"Am J Respir Crit Care."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1007\/s00431-020-03847-6","article-title":"Predicting nasal high-flow therapy failure by pediatric respiratory rate-oxygenation index and pediatric respiratory rate-oxygenation index variation in children.","volume":"180","author":"Yildizdas","year":"2021","journal-title":"Eur J Pediatr."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202203-0561LE","article-title":"A novel index to predict the failure of high-flow nasal cannula in patients with acute hypoxemic respiratory failure: A pilot study.","author":"Chen","year":"2022","journal-title":"Am J Respir Crit Care."},{"key":"B38","doi-asserted-by":"publisher","first-page":"639100","DOI":"10.3389\/fmolb.2021.63910","article-title":"High-flow nasal cannula for COVID-19 patients: A multicenter retrospective study in China.","volume":"8","author":"Duan","year":"2021","journal-title":"Front Mol Biosci."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.979944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T07:20:00Z","timestamp":1661239200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.979944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":38,"alternative-id":["10.3389\/fped.2022.979944"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.979944","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"article-number":"979944"}}